Optimizing SARS-CoV-2 Variant of Concern Screening: Experience from British Columbia, Canada, Early 2021
View ORCID ProfileCatherine A. Hogan, Hind Sbihi, Agatha Jassem, Natalie Prystajecky, John R. Tyson, Tracy D. Lee, Frankie Tsang, Corrinne Ng, Loretta Janz, Marc G. Romney, View ORCID ProfileLinda Hoang
doi: https://doi.org/10.1101/2021.03.23.21253520
Catherine A. Hogan
1British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada
MD, MScHind Sbihi
1British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada
2School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
PhDAgatha Jassem
1British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada
3Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
PhDNatalie Prystajecky
1British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada
3Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
PhDJohn R. Tyson
1British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada
PhDTracy D. Lee
1British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada
BScFrankie Tsang
1British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada
BMLScCorrinne Ng
1British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada
BScLoretta Janz
1British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada
BAMarc G. Romney
3Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
4Division of Medical Microbiology and Virology, St. Paul’s Hospital, Vancouver, British Columbia, Canada
MDLinda Hoang
1British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada
3Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
MD, MScData Availability
Data are available from the corresponding author upon reasonable request.
Posted March 26, 2021.
Optimizing SARS-CoV-2 Variant of Concern Screening: Experience from British Columbia, Canada, Early 2021
Catherine A. Hogan, Hind Sbihi, Agatha Jassem, Natalie Prystajecky, John R. Tyson, Tracy D. Lee, Frankie Tsang, Corrinne Ng, Loretta Janz, Marc G. Romney, Linda Hoang
medRxiv 2021.03.23.21253520; doi: https://doi.org/10.1101/2021.03.23.21253520
Optimizing SARS-CoV-2 Variant of Concern Screening: Experience from British Columbia, Canada, Early 2021
Catherine A. Hogan, Hind Sbihi, Agatha Jassem, Natalie Prystajecky, John R. Tyson, Tracy D. Lee, Frankie Tsang, Corrinne Ng, Loretta Janz, Marc G. Romney, Linda Hoang
medRxiv 2021.03.23.21253520; doi: https://doi.org/10.1101/2021.03.23.21253520
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2846)
- Dermatology (244)
- Emergency Medicine (429)
- Epidemiology (12558)
- Forensic Medicine (10)
- Gastroenterology (805)
- Genetic and Genomic Medicine (4432)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2850)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4191)
- Nursing (222)
- Nutrition (617)
- Oncology (2203)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (483)
- Public and Global Health (6779)
- Radiology and Imaging (1489)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)